+

WO2010149794A3 - Nouvelle composition pharmaceutique comprenant du poly(allylamine-co-n,n'-diallyl-1,3-diamino-2-hydroxypropane) - Google Patents

Nouvelle composition pharmaceutique comprenant du poly(allylamine-co-n,n'-diallyl-1,3-diamino-2-hydroxypropane) Download PDF

Info

Publication number
WO2010149794A3
WO2010149794A3 PCT/EP2010/059149 EP2010059149W WO2010149794A3 WO 2010149794 A3 WO2010149794 A3 WO 2010149794A3 EP 2010059149 W EP2010059149 W EP 2010059149W WO 2010149794 A3 WO2010149794 A3 WO 2010149794A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
allylamin
hydroxypropane
diallyl
diamino
Prior art date
Application number
PCT/EP2010/059149
Other languages
English (en)
Other versions
WO2010149794A2 (fr
Inventor
Sergio Lloret Pérez
Laura Díaz Guasch
Original Assignee
Combino Pharm, S.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200930368A external-priority patent/ES2350999B1/es
Application filed by Combino Pharm, S.L. filed Critical Combino Pharm, S.L.
Publication of WO2010149794A2 publication Critical patent/WO2010149794A2/fr
Publication of WO2010149794A3 publication Critical patent/WO2010149794A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

Cette invention concerne une composition pharmaceutique solide administrée par voie orale et comprenant environ 80 % à environ 94 % en poids de sévélamer y compris l'eau d'hydratation et au moins un excipient pharmaceutiquement acceptable.
PCT/EP2010/059149 2009-06-26 2010-06-28 Nouvelle composition pharmaceutique comprenant du poly(allylamine-co-n,n'-diallyl-1,3-diamino-2-hydroxypropane) WO2010149794A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
ES200930368 2009-06-26
ES200930368A ES2350999B1 (es) 2009-06-26 2009-06-26 Nueva composición farmacéutica comprendiendo hidrocloruro de poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxi propano).
EPPCT/EP2009/058122 2009-06-29
PCT/EP2009/058122 WO2010149230A1 (fr) 2009-06-26 2009-06-29 Nouvelle composition pharmaceutique comprenant du chlorhydrate de poly(allylamine-co-n,n'-diallyl-1,3-diamino-2-hydroxypropane)
ARP100102272A AR077244A1 (es) 2009-06-26 2010-06-25 Composicion farmaceutica que comprende poli (alilamin-co-n,n'-dialil-1,3-diamino-2-hidroxipropano )
ARP20100102272 2010-06-25

Publications (2)

Publication Number Publication Date
WO2010149794A2 WO2010149794A2 (fr) 2010-12-29
WO2010149794A3 true WO2010149794A3 (fr) 2011-06-16

Family

ID=43386953

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/059149 WO2010149794A2 (fr) 2009-06-26 2010-06-28 Nouvelle composition pharmaceutique comprenant du poly(allylamine-co-n,n'-diallyl-1,3-diamino-2-hydroxypropane)

Country Status (1)

Country Link
WO (1) WO2010149794A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103159881A (zh) * 2011-12-14 2013-06-19 上海亿法医药科技有限公司 盐酸司维拉姆的制备方法
CN103159880B (zh) * 2011-12-14 2016-06-22 上海亿法医药科技有限公司 碳酸司维拉姆的制备方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2545907A1 (fr) * 2011-07-15 2013-01-16 Combino Pharm, S.L. Procédé de granulation humide aqueuse pour polymères de polyallylamine réticulés
CN111773190A (zh) * 2020-06-24 2020-10-16 北京瑞迪道森医药科技有限公司 一种提高制剂安全性的碳酸司维拉姆片及其制备方法
CN118924783B (zh) * 2024-10-15 2025-05-16 湖州亚瑟制药有限公司 一种用于控制高磷血症的制剂组合物制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001028527A2 (fr) * 1999-10-19 2001-04-26 Geltex Pharmaceuticals, Inc. Noyau de comprime polymere par compression directe
WO2007094779A1 (fr) * 2006-02-14 2007-08-23 Teva Pharmaceutical Industries Ltd. Formules pharmaceutiques de polymères d'amines aliphatiques et méthodes de fabrication desdites formules
WO2008062437A2 (fr) * 2006-09-01 2008-05-29 Usv Limited Procédé de préparation d'hydrochlorure de sevelamer et formulation de celui-ci
WO2009034540A1 (fr) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Composition pharmaceutique à base de sevelamer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW592727B (en) 1997-04-04 2004-06-21 Chugai Pharmaceutical Co Ltd Phosphate-binding polymer preparations

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001028527A2 (fr) * 1999-10-19 2001-04-26 Geltex Pharmaceuticals, Inc. Noyau de comprime polymere par compression directe
WO2007094779A1 (fr) * 2006-02-14 2007-08-23 Teva Pharmaceutical Industries Ltd. Formules pharmaceutiques de polymères d'amines aliphatiques et méthodes de fabrication desdites formules
WO2008062437A2 (fr) * 2006-09-01 2008-05-29 Usv Limited Procédé de préparation d'hydrochlorure de sevelamer et formulation de celui-ci
WO2009034540A1 (fr) * 2007-09-11 2009-03-19 Ranbaxy Laboratories Limited Composition pharmaceutique à base de sevelamer

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103159881A (zh) * 2011-12-14 2013-06-19 上海亿法医药科技有限公司 盐酸司维拉姆的制备方法
CN103159881B (zh) * 2011-12-14 2016-04-27 上海亿法医药科技有限公司 盐酸司维拉姆的制备方法
CN103159880B (zh) * 2011-12-14 2016-06-22 上海亿法医药科技有限公司 碳酸司维拉姆的制备方法

Also Published As

Publication number Publication date
WO2010149794A2 (fr) 2010-12-29

Similar Documents

Publication Publication Date Title
MX2012000369A (es) Forma de dosificacion resistente a la manipulacion para opioides sensibles a la oxidacion.
WO2010146179A3 (fr) Composition pharmaceutique solide comprenant du rivaroxaban
EP3626253A3 (fr) Formulations stables de linaclotide
WO2011012322A3 (fr) Synthèse et utilisation de vildagliptine pour préparer des formes galéniques pharmaceutiques
WO2008012622A3 (fr) Composés d'azabenzimidazolyle
WO2008122965A3 (fr) Compositions pharmaceutiques à base de cyclosporine
WO2007135527A3 (fr) Composés de benzimidazolyle
WO2010092090A3 (fr) Nouveaux sels de la sitagliptine
WO2011076749A3 (fr) Forme solide de dosage pharmaceutique
IL214942A (en) N, n– Dimethyl-5– (2-methyl-6 - ((5-methylpyrazine-2-yl) carbamole) Benzoporen-4-Iloxy) Pyrimidine-2-carboxamide and the salts common in its pharmacies, pharmaceuticals containing them and their uses in the preparation of drugs
UA105766C2 (uk) Фармацевтична композиція, яка містить сіль стронцію, вітамін d і циклодекстрин
WO2011110939A3 (fr) Compositions pharmaceutiques de benzhydrylpipérazines substituées
WO2012087255A3 (fr) Formulations pharmaceutiques
WO2009081174A3 (fr) Combinaison antirétrovirale
WO2012075362A3 (fr) Modulateurs du récepteur cxcr4 de la chimiokine et leurs utilisations
JP2009537554A5 (fr)
MX2013000474A (es) Derivados de arilamida novedosos que tienen propiedades antiandrogenicas.
WO2010132765A3 (fr) Analogues d'aminoglycoside antibactériens
WO2010049449A3 (fr) Nouveaux sels de sunitinib
MY152951A (en) Solid pharmaceutical fixed dose compositions comprising irbesartan and amlodipine, their preparation and their therapeutic application
WO2008129501A3 (fr) Compositions pharmaceutiques de duloxetine
EP2241310A3 (fr) Formulations à libération modifiée d'émoxypine
WO2010149794A3 (fr) Nouvelle composition pharmaceutique comprenant du poly(allylamine-co-n,n'-diallyl-1,3-diamino-2-hydroxypropane)
EP2384746A3 (fr) Compositions de comprimé oral de dexlansoprazole à libération duale
WO2010046933A3 (fr) Compositions pharmaceutiques de linézolid à goût masqué

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10730415

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10730415

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载